Douglas Carr Receives Stock Award at Century Therapeutics Inc (IPSC) — SEC Form 4, May 17, 2023

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Douglas Carr

SVP

TXN 2023-05-15 · FILED 2023-05-17

Equity Position 321K sh 200,545 → 321,391

Equity Change +60.3% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Century Therapeutics Inc

IPSC CIK 0001850119

Reporting Owner

Name	Relationship
Douglas Carr CIK 0001867173	SVP

Douglas Carr at Century Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $28,577

More from this insider at Century Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2023-05-15	A - Award/Grant	120,846 A	$0.00	—	321,391	Direct

Footnotes (1)

F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs shall vest 50% on November 1, 2023, with the remaining 50% vesting upon the earlier of: (i) November 1, 2024; and (ii) satisfaction of certain performance criteria, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Century Therapeutics Inc

GET /v1/forms/4/0001062993-23-011404 API docs